NEURAXIS, INC. (NRXS) Operating Margin
- Operating margin · 12 months: Value -144.51%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -144.51% | Operating income / revenue. Period ending 2026-06-30. $-7.68M ÷ $5.32M × 100 ≈ -144.51% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -7.68M USD | Operating Income (Loss) |
| Revenue | 5.32M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 767.74K USD | Cost of Goods and Services Sold |
| Research and development | 645.32K USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-7.68M | $5.32M | $767.74K | $645.32K | (m) | -144.51% |
| 2026-03-31 | $-7.28M | $4.28M | $641.81K | $475.31K | (m) | -169.93% |
| 2025-12-31 | $-7.83M | $3.57M | $562.92K | $493.61K | (m) | -219.37% |
| 2025-09-30 | $-7.58M | $3.36M | $526.32K | $258.35K | (m) | -225.43% |
| 2025-06-30 | $-7.13M | $3.22M | $499.58K | $254.24K | (m) | -221.62% |
| 2025-03-31 | $-7.62M | $2.93M | $426.40K | $261.09K | (m) | -259.62% |
| 2024-12-31 | $-7.16M | $2.69M | $362.00K | $206.11K | (m) | -266.46% |
| 2024-09-30 | $-7.31M | $2.46M | $329.29K | $130.08K | (m) | -297.75% |
| 2024-06-30 | $-8.69M | $2.27M | $288.17K | $102.61K | (m) | -383.30% |
| 2024-03-31 | $-7.60M | $2.30M | $282.53K | $158.09K | (m) | -330.22% |
| 2023-12-31 | $-6.66M | $2.46M | $303.35K | $169.31K | (m) | -270.91% |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-3.37M | $2.68M | $297.06K | $225.61K | (m) | -125.61% |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |